Interviews ID Factors Tied to COVID-19 Vaccine Hesitancy in Black Women
By Lori Solomon HealthDay Reporter
TUESDAY, Jan. 14, 2025 -- Three main themes may largely explain COVID-19 vaccine hesitancy among Black women in the United States: mistrust in health care and government, concerns over vaccine safety, and disapproval of coercive vaccine communication, according to a study published online Jan. 9 in JAMA Network Open.
Brittany C. Slatton, Ph.D., from the College of Liberal Arts and Behavioral Sciences at Texas Southern University in Houston, and colleagues explored factors associated with COVID-19 vaccine hesitancy among U.S. Black women. The analysis included interviews from 54 Black women (aged 21 to 66 years).
The researchers found that three primary themes emerged, including (1) mistrust in health care and government, rooted in past medical exploitation; (2) concerns over vaccine safety and long-term effects, particularly regarding reproductive health; and (3) ineffective and coercive vaccine communication and promotion. Many women reported the desire for more comprehensive education about vaccine mechanisms and disapproved of the use of coercive financial incentives and celebrity endorsements in vaccine promotion.
"Addressing COVID-19 vaccine hesitancy among Black women requires a multifaceted approach that acknowledges historical traumas, provides clear and transparent safety information, and avoids coercive vaccine promotion strategies," the authors write. "These findings emphasize the need for health care practitioners and public health officials to prioritize trust-building, engage community leaders, and tailor interventions to address the unique concerns of Black women to improve vaccine confidence and uptake."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Further Support and Information on COVID-19
Read this next
35 Percent of Eligible Children Receive RSV Prophylaxis With Nirsevimab
TUESDAY, July 22, 2025 -- Despite near universal availability of nirsevimab, only 35 percent of eligible children receive nirsevimab for respiratory syncytial virus (RSV)...
2020 to 2024 Saw Drop in Flu Vaccine Uptake Among U.S. Adults
FRIDAY, July 18, 2025 -- There was an overall decrease in influenza vaccine uptake among U.S. adults from 2020 to 2024, according to a study published online July 16 in PLOS...
No Risks Seen With Early Childhood Exposure to Aluminum-Adsorbed Vaccines
TUESDAY, July 15, 2025 -- Early childhood exposure to aluminum-adsorbed vaccines is not associated with an increased risk for autoimmune, atopic or allergic, or neurodevelopmental...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.